3 Without insurance, GLP-1s can cost between $892 to $1,300+ per month, and insurers are far less likely to reimburse the cost of drugs prescribed for off-label use
Efficacy and safety of oral semaglutide monotherapy vs placebo in a predominantly Chinese population with type 2 diabetes (PIONEER 11): a double-blind , Phase IIIa , randomised trial
Tirzepatide, found in Mounjaro and Zepbound, is a dual-agonist (targeting both GLP-1 and GIP receptors)
Although the study did not include molecular imaging or tissue analysis, Bilchick said the observation that AFib reduction occurred independently of weight loss supports the possibility of an inflammatory mechanism
And I think that, you know, again, thats why a doctor thats scripting that then says, come back monthly or come back quarterly and let me know how youre doing is not the right model for these medications